|
|
|
Delaware
|
|
45-3757789
|
(State or other jurisdiction of
incorporation or organization)
|
|
(IRS Employer
Identification Number)
|
|
|
|
200 Cardinal Way, 2nd Floor
Redwood City, California
|
|
94063
|
(Address of principal executive offices)
|
|
(Zip code)
|
|
|
Stephen B. Thau
Alfredo B. D. Silva
Morrison & Foerster LLP
425 Market Street
San Francisco, California 94105
(415) 268-7000
|
Large accelerated filer
|
¨
|
|
|
Accelerated filer
|
¨
|
Non-accelerated filer
|
þ
|
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
¨
|
|
|
|
|
Emerging growth company
|
þ
|
Title of securities to be registered
|
|
Amount to be
Registered (1) |
|
Proposed
maximum
offering price
per share
|
|
Proposed
maximum
aggregate
offering
price
|
|
Amount of
registration
fee
|
Common Stock, $0.0001 par value per share
|
|
|
|
|
|
|
|
|
-- 2011 Stock Incentive Plan, as amended
|
|
2,506,926
|
|
$3.50 (2)
|
|
$8,774,241
|
|
$1,092.39
|
-- 2018 Omnibus Incentive Plan
|
|
3,000,000 (3)
|
|
$25.80 (4)
|
|
$7,400,000
|
|
$9,636.30
|
-- 2018 Employee Stock Purchase Plan
|
|
325,000 (5)
|
|
$21.93 (6)
|
|
$7,127,250
|
|
$887.35
|
TOTAL
|
|
5,831,926
|
|
|
|
$93,301,491
|
|
$11,616.03
|
(1)
|
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of common stock that become issuable under Menlo Therapeutics Inc.’s 2011 Stock Incentive Plan, as amended (the “2011 Plan”), 2018 Omnibus Incentive Plan (the “2018 Plan”) and 2018 Employee Stock Purchase Plan (the “ESPP” and, together with the 2018 Plan and the 2011 Plan, as amended, the “Plans”), by reason of certain corporate transactions or events, including any share dividend, share split, recapitalization or certain other similar transactions effected without the Registrant’s receipt of consideration that result in an increase in the number of the outstanding shares of the common stock. In addition, pursuant to Rule 416(c) under the Securities Act, this Registration Statement also covers an indeterminate amount of interests to be offered or sold pursuant to the employee benefits plan described herein.
|
(2)
|
Estimated in accordance with Rules 457(c) and (h) under the Securities Act solely for the purpose of calculating the registration fee. The price of $3.50 per share represents the weighted average of the exercise prices for outstanding stock options under the 2011 Plan as of the date of this Registration Statement.
|
(3)
|
Represents shares of common stock reserved for issuance pursuant to stock option awards outstanding under the 2018 Plan as of the date of this Registration Statement. Any shares of common stock that are subject to stock option awards under the 2018 Plan that are forfeited or lapse or expire will be available for future issuance as common stock under the 2018 Plan.
|
(4)
|
Estimated in accordance with Rules 457(c) and (h) under the Securities Act solely for the purpose of calculating the registration fee based on the average high and low offering prices of the common stock on The Nasdaq Global Select Market on January 25, 2018.
|
(5)
|
Represents shares of common stock reserved for future issuance under the ESPP.
|
(6)
|
Estimated in accordance with Rules 457(c) and (h) under the Securities Act solely for the purpose of calculating the registration fee based on 85% of the average high and low offering prices of the common stock on The Nasdaq Global Select Market on January 25, 2018. Pursuant to the ESPP, the purchase price of the shares of common stock reserved for issuance thereunder will be 85% of the lower of the fair market value of the common stock on (i) the first trading day of the offering period or (ii) the exercise date.
|
|
(1)
|
The Registrant’s final prospectus, dated January 26, 2018, filed with the Commission pursuant to Rule 424(b), relating to the Registration Statement on Form S-1, as amended (File No. 333-222324), which contains the Registrant’s audited financial statements for the latest fiscal year for which such statements have been filed; and
|
(2)
|
The description of the Registrant’s common stock contained in the Registrant’s Registration Statement on Form 8-A (File No. 001-38356) filed with the Commission on January 19, 2018, pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including any amendment or report filed for the purpose of updating such description.
|
(3)
|
The Registrant’s Current Report on Form 8-K filed on January 29, 2018.
|
Item 8.
|
Exhibits.
|
Exhibit No.
|
|
Description
|
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
||
|
|
|
By:
|
/s/ Steven Basta
|
|
Steven Basta
|
|
President and Chief Executive Officer
|
Name
|
|
Capacity
|
|
Date
|
/s/ Steven Basta
|
|
|
|
|
Steven Basta
|
|
President, Chief Executive Officer, and Director (Principal Executive Officer)
|
|
January 29, 2018
|
/s/ Kristine Ball
|
|
|
|
|
Kristine Ball
|
|
Senior Vice President, Corporate Strategy and Chief Financial Officer
(Principal Financial Officer)
|
|
January 29, 2018
|
/s/ Paul Berns
|
|
|
|
|
Paul Berns
|
|
Director
|
|
January 29, 2018
|
/s/ Albert Cha
|
|
|
|
|
Albert Cha
|
|
Director
|
|
January 29, 2018
|
/s/ Ted Ebel
|
|
|
|
|
Ted Ebel
|
|
Director
|
|
January 29, 2018
|
/s/ David McGirr
|
|
|
|
|
David McGirr
|
|
Director
|
|
January 29, 2018
|
/s/ Aaron Royston
|
|
|
|
|
Aaron Royston
|
|
Director
|
|
January 29, 2018
|
/s/ Scott Whitcup
|
|
|
|
|
Scott Whitcup
|
|
Director
|
|
January 29, 2018
|
|
425 MARKET STREET
SAN FRANCISCO CALIFORNIA 94105-2482
TELEPHONE: 415.268.7000
FACSIMILE: 415.268.7522
WWW.MOFO.COM
|
MORRISON FOERSTER LLP
BEIJING, BERLIN, BRUSSELS, DENVER,
HONG KONG, LONDON, LOS ANGELES, NEW YORK, NORTHERN VIRGINIA, PALO ALTO, SACRAMENTO, SAN DIEGO, SAN FRANCISCO, SHANGHAI, SINGAPORE, TOKYO, WASHINGTON, D.C. |